Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 37.47B | 37.47B | 37.12B | 34.17B | 28.28B | 27.94B |
Gross Profit | 16.65B | 16.39B | 16.04B | 14.29B | 11.37B | 11.67B |
EBITDA | 5.01B | 5.01B | 5.58B | 4.12B | 2.07B | 3.13B |
Net Income | 2.95B | 2.95B | 3.46B | 2.57B | 1.09B | 1.74B |
Balance Sheet | ||||||
Total Assets | 73.89B | 73.89B | 73.16B | 67.16B | 63.37B | 61.67B |
Cash, Cash Equivalents and Short-Term Investments | 27.10B | 27.10B | 28.44B | 29.40B | 27.08B | 26.63B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 6.53B | 6.53B | 7.42B | 6.71B | 5.63B | 5.15B |
Stockholders Equity | 67.36B | 67.36B | 65.75B | 60.45B | 57.74B | 56.52B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 945.00M | 343.00M | 2.69B | 1.43B | 1.69B |
Operating Cash Flow | 0.00 | 2.90B | 2.21B | 3.42B | 2.08B | 2.97B |
Investing Cash Flow | 0.00 | -2.67B | -3.67B | 2.48B | -3.44B | 732.00M |
Financing Cash Flow | 0.00 | -1.39B | -1.12B | -718.00M | -717.00M | -1.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥5.36B | 4.02 | ― | 1.33% | 13.09% | ||
80 Outperform | ¥46.60B | 18.55 | 4.56% | -2.28% | -43.48% | ||
74 Outperform | ¥42.83B | 18.83 | 2.73% | -1.19% | -30.24% | ||
73 Outperform | ¥30.84B | 8.06 | 2.53% | 16.42% | 79.16% | ||
61 Neutral | $36.69B | 12.42 | -10.20% | 1.85% | 8.50% | -7.32% | |
49 Neutral | ¥3.78B | 29.94 | 2.04% | 0.35% | ― |
Icom Incorporated reported a decline in its financial performance for the nine months ended December 31, 2024, with net sales and profits experiencing significant drops compared to the previous year. Despite the downturn, the company maintains a strong equity-to-asset ratio, indicating a stable financial position, and projects modest growth in net sales and operating profit for the full fiscal year ending March 31, 2025.